Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 3, 2007 - Issue 2
Submit an article Journal homepage
219
Views
15
CrossRef citations to date
0
Altmetric
Technology Evaluation

High-throughput in vitro hemotoxicity testing and in vitro cross-platform comparative toxicity

Ivan N Rich Founder, Chairman & CEO, HemoGenix, Inc., 4405 N. Chestnut Street, Suite D, Colorado Springs, CO 80907, USA. [email protected]
Pages 295-307 | Published online: 11 Apr 2007

Bibliography

  • BRADLEY TR, METCALF D: The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. (1966) 44:287.
  • PLUZNIK DH, SACHS L: The induction of clones of normal mast cells by a substance from conditioned medium. Exp. Cell. Res. (1966) 43:553.
  • PESSINA A, ALBELLA B, BAYO M et al.: Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol. Sci. (2003) 75:355-367.
  • BRADLEY TR, HODGSON GS, ROSENDAAL M: The effect of oxygen tension on haemopoietic and fibroblast cell proliferation in vitro. J. Cell. Physiol. (1978) 97:517-522.
  • RICH IN, KUBANEK B: The effect of reduced oxygen tension on colony formation of erythropoietic cells in vitro. Br. J. Haematol. (1982) 52:579-588.
  • RICH IN: A role for the macrophage in normal hemopoiesis: I. Functional capacity of bone-marrow-derived macrophages to release hemopoietic growth factors. Exp. Hematol. (1986) 14(8):738-745.
  • RICH IN: A role for the macrophage in normal hemopoiesis: II. Effect of varying physiological oxygen tensions on the release of hemopoietic growth factors from bone-marrow-derived macrophages in vitro. Exp. Hematol. (1986) 14(8):746-751.
  • RICH IN: The effect of 5-fluorouracil on erythropoiesis. Blood (1991) 77:1164-1170.
  • RICH IN: The developmental biology of hemopoiesis: effect of growth factors on colony formation by embryonic cells. Exp. Hematol. (1992) 20:368-370.
  • PARCHMENT RE: Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity. Environ. Health Perspect. (1998) 106(Suppl. 2):541-557.
  • PARCHMENT RE, HUANG M, ERICKSON-MILLER CL: Roles for in vitro myelotoxicity tests in preclinical drug development and clinical trial planning. Toxicol. Pathol. (1993) 21:241-250.
  • PARCHMENT RE, GORDON M, GRIESHABER CK, SESSA C, VOLPE D, GHIELMINI M: Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. Ann. Oncol. (1998) 9:357-364.
  • NATIONAL INSTITUTES OF HEALTH: Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity. NIH Publication No. 01-4499 (2002).
  • GRIBALDO L, BUEREN J, DELDAR A et al.: The use of in vitro systems for evaluating haematotoxicity. The Report and Recommendations of ECVAM Workshop 14. ATLA (1997) 24:211-231.
  • PRIETO P: ECVAM’s in-house prevalidation/validation studies in the areas of haematotoxicity, reproductive toxicity, metabolism-mediated toxicity and epithelial barrier function. Sci. Total Environ. (2000) 247:349-354.
  • RICH IN, HALL KM: Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Toxicol. Sci. (2005) 87:427-441.
  • SCHOFIELD R: The stem cell system. Biomed. Pharmacother. (1983) 37:375-380.
  • LI L: The stem cell niches in the bone. J. Clin. Invest. (2006) 116:1195-1201.
  • DEXTER TM, ALLEN TD, LAJTHA LG: Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. (1977) 91:335-344.
  • PLOEMACHER RE, VAN DER SLUIJS JP, VOERMAN JS, BRONS NH: An in vitro limiting-dilution assay of long-term repopulating hemopoietic stem cells in the mouse. Blood (1989) 74:2755-2763.
  • SUTHERLAND HJ, EAVES CJ, EAVES AC, DRAGOWSKA W, LANSDORP PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood (1989) 74:1563-1570.
  • LEVI F: From circadian rhythms to cancer chronotherapeutics. Chronobiol. Int. (2002) 19:1-19.
  • BERTHEAULT-CVITKOVIC F, JAMI A, ITHZAKI M et al.: Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic cancer. J. Clin. Oncol. (1996) 14:2950-2958.
  • HRUSHESKY WJM, DELL I, EATON J, HALBERG F: Circardian-stage-dependent effect of doxorubicin upon reduced glutathione in the murine heart. Proc. Am. Assoc. Cancer Res. (1982) 23:12.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.